Cantitate/Preț
Produs
Total produse
Vezi coșul
The Metabolic Syndrome: Pharmacology and Clinical Aspects de Henning Beck-Nielsen

The Metabolic Syndrome: Pharmacology and Clinical Aspects

Editat de Henning Beck-Nielsen
en Limba Engleză Paperback – 8 apr 2015
The metabolic syndrome is a common syndrome affecting about 20 % of the adult population in Europe, and probably the prevalence is of the same magnitude in other industrialised countries worldwide. It is mainly caused by western lifestyle resulting in abdominal obesity, but also a genetic predisposition plays a role. This syndrome, which is linked to leisure lifestyle and overeating/obesity, can develop into type 2 diabetes, cardiovascular disease and cancer. Therefore, proper treatment and prevention are heavily needed. This book discusses lifestyle intervention and treatment, specifically with pharmacological compounds, in order to formulate a strategy for treating the metabolic syndrome in the daily clinic.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 125463 lei  6-8 săpt.
  SPRINGER VIENNA – 8 apr 2015 125463 lei  6-8 săpt.
Hardback (1) 126518 lei  6-8 săpt.
  SPRINGER VIENNA – 8 apr 2013 126518 lei  6-8 săpt.

Preț: 125463 lei

Preț vechi: 132067 lei
-5% Nou

Puncte Express: 1882
Preț estimativ în valută:
24011€ • 24941$ • 19945£

Carte tipărită la comandă

Livrare economică 01-15 februarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783709116852
ISBN-10: 3709116856
Pagini: 244
Ilustrații: XI, 229 p.
Dimensiuni: 155 x 235 x 13 mm
Greutate: 0.35 kg
Ediția:2013
Editura: SPRINGER VIENNA
Colecția Springer
Locul publicării:Vienna, Austria

Public țintă

Research

Cuprins

Introduction and definition of the metabolic syndrome.- Epidemiology of the metabolic syndrome.- Pathophysiology of the metabolic syndrome.- Metabolic syndrome and cardiovascular diseases.- Lifestyle intervention – prevention of complications to the metabolic syndrome.- Treatment with metformin.- Treatment with thiazolidinediones (TZDs).- Treatment with PPARalpha activators.- The role of statins in the metabolic syndrome.- Antithrombotic and fibroanalytic treatment in the metabolic syndrome.- The role of GLP agonists in the metabolic syndrome.- Treatment of the metabolic syndrome by gastric bypass.- Treatment of the metabolic syndrome in the daily clinic – algorithms.- Future perspectives​.

Textul de pe ultima copertă

Metabolic syndrome is a common syndrome affecting about 20% of the adult population in Europe, and the prevalence is likely similar in other industrialised countries worldwide. It is mainly caused by the western lifestyle, which tends to produce abdominal obesity, but a genetic predisposition also plays a part. This syndrome, which is linked to leisure lifestyles and overeating/obesity, can develop into type 2 diabetes, cardiovascular disease and cancer. Therefore, proper treatment and prevention are essential. This book discusses lifestyle intervention and treatment, specifically with pharmacological compounds, in order to formulate a strategy for treating the metabolic syndrome in daily practice.

Caracteristici

Gives a clear overview to the basics and the clinical aspects of the topic
Comprehensively shows the current potential of pharmacological treatment of the metabolic syndrome
Introduces new concepts to each described way of treatment​

Descriere

The metabolic syndrome is a common syndrome affecting about 20 % of the adult population in Europe, and probably the prevalence is of the same magnitude in other industrialised countries worldwide. It is mainly caused by western lifestyle resulting in abdominal obesity, but also a genetic predisposition plays a role. This syndrome, which is linked to leisure lifestyle and overeating/obesity, can develop into type 2 diabetes, cardiovascular disease and cancer. Therefore, proper treatment and prevention are heavily needed. This book discusses lifestyle intervention and treatment, specifically with pharmacological compounds, in order to formulate a strategy for treating the metabolic syndrome in the daily clinic.